Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0042493; response to drug | 5.871E-07 | 8.522E-04 | ABCC1, ABCG2, APEX1, CA3, CA9, CDK2, CDK6, NFKB1, POLB |
BP | GO:0009987; cellular process | GO:0006286; base-excision repair, base-free sugar-phosphate removal | 2.026E-06 | 1.838E-03 | APEX1, POLB |
BP | GO:0008152; metabolic process | GO:2001303; lipoxin A4 biosynthetic process | 2.026E-06 | 1.838E-03 | ALOX12, ALOX15 |
BP | GO:0065007; biological regulation | GO:0065008; regulation of biological quality | 2.393E-06 | 2.084E-03 | ABCC1, ABCG2, ACHE, ALOX12, ALOX15, APEX1, CA12, CA2, CA7, CDK6, CYP19A1, GAA, MAPT, NFKB1, POLB, XDH |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.074E-06 | 4.408E-03 | CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 1.193E-05 | 7.772E-03 | ABCC1, ALOX12, ALOX15 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.610E-18 | 3.346E-14 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.910E-16 | 8.317E-13 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 2.026E-06 | 1.838E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 6.074E-06 | 4.408E-03 | ALOX12, ALOX15 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 6.981E-03 | 3.840E-02 | XDH |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.393E-03 | 2.936E-02 | ALOX15; ALOX12 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.184E-22 | 1.042E-20 | CA12; CA1; CA3; CA2; CA5A; CA7; CA6; CA9; CA14 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 1.288E-03 | 1.620E-02 | GAA; ALOX15; ALPL; ALOX12; CYP19A1; HSD17B10; XDH |
hsa02010 | ABC transporters_Homo sapiens_hsa02010 | 1.724E-03 | 1.686E-02 | ABCC1; ABCG2 |
hsa03410 | Base excision repair_Homo sapiens_hsa03410 | 9.715E-04 | 1.602E-02 | POLB; APEX1 |
hsa04115 | p53 signaling pathway_Homo sapiens_hsa04115 | 4.184E-03 | 2.936E-02 | CDK6; CDK2 |
hsa04976 | Bile secretion_Homo sapiens_hsa04976 | 4.425E-03 | 2.936E-02 | CA2; ABCG2 |
hsa05010 | Alzheimer's disease_Homo sapiens_hsa05010 | 1.634E-03 | 1.686E-02 | BACE1; MAPT; HSD17B10 |
hsa05161 | Hepatitis B_Homo sapiens_hsa05161 | 1.092E-03 | 1.602E-02 | CDK6; CDK2; NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
C00-D49: Neoplasms | Acute lymphoblastic leukemia | C91.0 | CDK2 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1 |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | CDK2 |
C00-D49: Neoplasms | Colon cancer | C50 | ALPL |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1 |
C00-D49: Neoplasms | Thymoma | C37, D15.0 | CDK2 |